Skip to main content
Caplight Logo









Trace Orthopedics

Trace Orthopedics

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.traceorthopedics.com/

Last Round

Angel

Dec 1, 2023

Est. Valuation

$4.5M

Total Funding Raised

$2.25M

Company Overview

Trace Orthopedics is a medical technology company that develops minimally invasive, needle-based fixation devices for the repair of partial tendon tears.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicetendon repairminimally invasive surgerypercutaneous surgeryorthopedic surgeryoutpatient surgerymusculoskeletal interventionminimally invasivekeyhole surgeryortho techmedtechsurgical implantambulatory surgery centerASCimage-guided surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Trace Orthopedics Comparables

Compare Trace Orthopedics with similar companies based on industry and business-model similarity.

Trace Orthopedics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aztron Medtech
81%
CoNextions Medical
74%
Arcuro Medical Ltd.
72%

Trace Orthopedics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelDec 1, 2023
Series AAug 22, 2022
SeedNov 1, 2021

Trace Orthopedics Investors

Notable investors and investment history

Trace Orthopedics investors
InvestorRounds
Central Texas Angel NetworkAngel
Accelerator Venture PartnersSeries A
Keiretsu Forum Mid-AtlanticSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 13, 2024

    Monthly visitors increased 37% MoM, from 584 to 798.

  • Oct 24, 2024

    Monthly visitors grew 115% MoM.

Recent news

Latest coverage and updates

  • is_developingAug 17, 2026

    Trace Orthopedics LLC is developing Tendon Fastener.

Trace Orthopedics Filings

Explore SEC and related filing metadata, where available.

Trace Orthopedics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Trace Orthopedics's valuation, stock price, and market status.

Is Trace Orthopedics a public or private company?

Trace Orthopedics is a private company.

What is the current stock price of Trace Orthopedics?

Trace Orthopedics is a private company with no public stock price. No recent secondary market data is available.

How much is Trace Orthopedics worth (valuation)?

Trace Orthopedics's valuation is estimated at $4.5M based on funding round data.

Can I buy Trace Orthopedics stock?

Trace Orthopedics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Trace Orthopedics's last funding round?

Trace Orthopedics's most recent funding round was Angel on August 22, 2022.

Who are the main investors in Trace Orthopedics?

Key investors in Trace Orthopedics include Keiretsu Forum Mid-Atlantic.

Will Trace Orthopedics IPO soon?

No public IPO plans have been announced for Trace Orthopedics.

How can I track Trace Orthopedics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Trace Orthopedics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range4
Year Founded2019
Last FundingDec 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?